Doctor talking to patient

ESG: One procedure. Sustainable weight loss for your patients.

With lifestyle changes, ESG provides a clinically proven, minimally invasive endoscopic option for weight loss.

Introducing Endoscopic Sleeve Gastroplasty (ESG)

endoscopic-sleeve-gastroplasty-esg

The IFSO Bariatric Endoscopy Committee endorses Endoscopic Sleeve Gastroplasty (ESG) as an effective and valuable treatment for obesity.1

ESG is a minimally invasive procedure designed to support gradual, lasting weight loss when combined with lifestyle changes.

It is particularly beneficial for patients with class I and II obesity, as well as for those with class III obesity who are not suitable candidates for metabolic bariatric surgery.1

No incisions or scars

Typically, a same-day procedure

Organ-sparing, and revisable

Preserves future treatment options

How the ESG procedure is performed

ESG reduces stomach size using sutures placed through the mouth during a simple outpatient procedure. It is performed under general anesthesia by a trained gastroenterologist or surgeon that uses the OverStitch™ System to create 6-8 plications along the greater curve of the stomach.

Curious to learn more about ESG? Here’s how it works:

Sustainable results

~70-80% stomach reduction

ESG helps people living with obesity eat less, feel fuller faster, and achieve significant, lasting weight loss when combined with lifestyle changes.

Proven weight loss that lasts

In the MERIT randomised clinical trial, ESG patients lost an average of 13.6% of total body weight at year 1.²

Minimal time away

Most patients typically go home the same day as the procedure and can return to routine daily activity in 2-3 days.²

Clinical evidence

Download our leaflet for a concise, evidence-based overview of ESG, showcasing the latest clinical data and insights that support its safety and efficacy.

Clinical Evidence in Primary Procedures

Filename
ESG-Clinical-Leaflet.pdf
Size
1 MB
Format
application/pdf
Download

Key Resources

ESG Physician Brochure

Filename
ESG-Physician-Brochure.pdf
Size
3 MB
Format
application/pdf
Download

Adopting ESG – Interview with Dr. Lubbe

Dr. Lubbe shares what led her to adopt the endoscopic approach in her bariatric department, with a focus on the role of ESG.

Resources for Patients

Discover comprehensive resources tailored for ESG patients across the UK, Italy, Germany, Spain, and France.

Patient Perspective: Joanna’s ESG Journey

Listen to Joanna’s story as she shares her transformative weight loss journey with ESG.

Endoscopic Sleeve Gastroplasty (ESG) for patients in the UK

Gastroplastica endoscopica per i pazienti in Italia

Endoskopische Schlauchmagen für Patienten in Deutschland

Gastroplastia endoscópica en manga para pacientes en España

Sleeve gastroplastie endoscopique pour les patients en France

   

Alternative bariatric procedures

  • Laparoscopic sleeve gastrectomy (LSG), also referred to as vertical sleeve gastrectomy, is a restrictive bariatric procedure predominantly performed via laparoscopy. During LSG, approximately 75-85% of the stomach is resected along the greater curvature. This procedure induces significant neurohormonal and bile signaling modifications, contributing to its metabolic efficacy.3
  • Roux-en-Y gastric bypass (RYGB) involves the exclusion of a portion of the stomach and proximal intestine, with the distal intestine reconfigured into a Y-configuration. This allows for the passage of ingested food from the upper gastric pouch through the Roux limb, facilitating both weight loss and metabolic benefits, independent of weight reduction.3

References

1. IFSO (International Federation for the Surgery of Obesity and Metabolic Disorders) Bariatric Endoscopy Committee Evidence‑Based Review and Position Statement on Endoscopic Sleeve Gastroplasty for Obesity Management. 2024.
2. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial. Barham K Abu Dayyeh et al. Lancet. 2022 Aug 6; 400(10350):441-451.
3. IFSO-WGO GUIDELINES ON OBESITY CONTENTS. 2022.

CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material is not intended for use in France.